CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • SLNO Dashboard
  • Financials
  • Filings
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Soleno Therapeutics (SLNO) News and press releases

Company Profile

News

From Benzinga Pro
Soleno Therapeutics Announces Peer-Reviewed Publication Of Results From Previously Completed Phase 3 Trial Of DCCR For Treatment Of Prader-Willi Syndrome
26 Jan 23
Biotech, News, General
Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that results from the
Kala Pharmaceuticals, Getty Images And This Bitcoin Stock Top Short Squeeze Leaderboard: 10 Short Squeeze Stocks To Watch
17 Jan 23
Cryptocurrency, News, Penny Stocks, Small Cap, Top Stories, Markets, Trading Ideas
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.
Watching Soleno Therapeutics; Zacks Investment Research Upgrades To Strong Buy
13 Jan 23
Upgrades, Analyst Ratings
https://www.zacks.com/stock/news/2039232/soleno-therapeutics-inc-slno-upgraded-to-strong-buy-what-does-it-mean-for-the-stock
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
27 Dec 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
20 Dec 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
Peering Into Soleno Therapeutics's Recent Short Interest
20 Dec 22
Short Sellers, Short Ideas, Trading Ideas
Soleno Therapeutics's (NASDAQ:SLNO) short percent of float has risen 65.08% since its last report. The company recently reported that it has 86 thousand shares sold short, which is 5.2% of all regular shares that are available for trading.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
20 Dec 22
Movers
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
20 Dec 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
12 Health Care Stocks Moving In Monday's After-Market Session
19 Dec 22
Movers
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
19 Dec 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
12 Health Care Stocks Moving In Monday's Intraday Session
19 Dec 22
Movers
Soleno Therapeutics Announces Financing Commitment For Up To $60M
19 Dec 22
News, Financing
Funding from three leading healthcare investors, with Vivo Capital joining existing investors Nantahala Capital and Abingworth $10 million capital infusion at closing and $15 million upon positive
Soleno Therapeutics Q3 EPS $(0.76) Up From $(1.50) YoY
9 Nov 22
Earnings, News
Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.76) per share. This is a 49.33 percent increase over losses of $(1.50) per share from the same period last year.

Press releases

From Benzinga Pro
Thinking about buying stock in Mullen Automotive, Soleno Therapeutics, Agrify, AMC Entertainment, or Amyris?
19 Dec 22
Small Cap, Opinion, Press Releases
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MULN, SLNO, AGFY, AMC, and AMRS.
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
9 Nov 22
Earnings, Press Releases
REDWOOD CITY, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases,
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn